Lee S. Schwartzberg, MD, FACP, is a Medical Oncologist and Hematologist at West Cancer Center. Dr. Schwartzberg’s major research interests are new therapeutic approaches to breast cancer, targeted therapy and supportive care. He specializes in the treatment of breast cancer.
Titles and Roles
- Executive Director, West Cancer Center
- Chief, Division of Hematology/Oncology, the University of Tennessee Health Science Center
- Professor of Medicine, Division of Hematology/Oncology, the University of Tennessee Health Science Center
- Medical Director, West Clinic
- President/CMO, Vector Oncology
- Board of Directors, National Comprehensive Care Network
Areas of Expertise
- Breast Cancer
- Supportive Care
- Precision Oncology
Lee S. Schwartzberg, MD, FACP, is the Executive Director of West Cancer Center and is the Medical Director and a senior partner of West Clinic. He is a Professor of Medicine and Chief of the Division of Hematology/Oncology at the University of Tennessee Health Science Center. He also serves as President/CMO for Vector Oncology, an oncology specific SMO/CRO. Dr. Schwartzberg was the founding editor-in-chief of the journal Community Oncology and currently serves as the editor-in-chief of the Practice Update Oncology website. He serves on the editorial board of both the Journal of Supportive Oncology and The ASCO Post, in addition to serving as a reviewer for many prominent medical journals, including the New England Journal of Medicine and the Journal of Clinical Oncology. Dr. Schwartzberg is also a member of the board of directors for the National Comprehensive Cancer Network. His major research interests are new therapeutic approaches to breast cancer, targeted therapy and supportive care. He has published more than 150 research papers during his oncology career. Dr. Schwartzberg is board certified in internal medicine, hematology, and medical oncology. He maintains a private practice in medical oncology focusing on breast cancer.
Education and Training
Dr. Lee Schwartzberg graduated from State University of New York at Buffalo with a B.A. in biology and a M.S. in biochemistry. He attended medical school at New York Medical College. Dr. Schwartzberg did his internal medicine residency at Cornell University/North Shore University Hospital in Manhasset, New York. He completed his fellowship training in medical oncology and hematology at Memorial Sloan Kettering Cancer Center, where he also served as Chief Medical Resident and was a founding member of the institutional ethics committee.
Dr. Schwartzberg’s recent awards include:
- The ASCO Cancer Foundation Clinical Trials Participation Award
- The 2004 Jefferson Award for Community Service
- America’s Top Doctors, Oncology, 2007- present
- American College of Physicians Tennessee Chapter Volunteerism Award
- Memphis Business Journal Health Care Hero Award for Medical Innovation
Dr. Schwartzberg’s current research projects include:
- New approaches to HER2+ breast cancer
- Neoadjuvant therapy with Androgen receptor modulators in breast cancer
- Molecular profiling of triple negative breast cancer
- New approaches to chemotherapy induced nausea and vomiting
Dr. Schwartzberg has published more than 150 peer reviewed articles in elite journals, including the Journal of Clinical Oncology, Lancet Oncology, and Annals of Oncology.
To view Dr. Schwartzberg’s recent publications, click here.
Fight On in Memphis
For Dr. Schwartzberg, fighting cancer is a calling, and the West Cancer Center is a dream come true.
The best cancer treatment programs in the world are the programs that can treat all forms of cancer in one place. That is why Dr. Schwartzberg is excited about the new partnership of the West Cancer Center. With everything under one roof, research, doctors and technology can stay close to a patient’s bedside. Patients have always had an edge over cancer with Dr. Schwartzberg on their team. The West Cancer Center gives them the added advantage of home.
“‘No stone left unturned’ is our philosophy. Our new partnership helps all patients get the best care possible.”